| Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas RAS Santos, ACS e Silva, C Maric, DMR Silva, RP Machado, I de Buhr, ... Proceedings of the National Academy of Sciences 100 (14), 8258-8263, 2003 | 1705 | 2003 |
| G-protein–coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor E Kostenis, G Milligan, A Christopoulos, CF Sanchez-Ferrer, ... Circulation 111 (14), 1806-1813, 2005 | 551 | 2005 |
| Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors JB Pesquero, RC Araujo, PA Heppenstall, CL Stucky, JA Silva Jr, ... Proceedings of the National Academy of Sciences 97 (14), 8140-8145, 2000 | 472 | 2000 |
| Transgenic rat model of Huntington's disease S von Hörsten, I Schmitt, HP Nguyen, C Holzmann, T Schmidt, T Walther, ... Human molecular genetics 12 (6), 617-624, 2003 | 429 | 2003 |
| Angiotensin (1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart C Mercure, A Yogi, GE Callera, AB Aranha, M Bader, AJ Ferreira, ... Circulation research 103 (11), 1319-1326, 2008 | 314 | 2008 |
| Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents F Gembardt, A Sterner-Kock, H Imboden, M Spalteholz, F Reibitz, ... Peptides 26 (7), 1270-1277, 2005 | 267 | 2005 |
| Sustained long term potentiation and anxiety in mice lacking themas protooncogene T Walther, D Balschun, JP Voigt, H Fink, W Zuschratter, C Birchmeier, ... Journal of Biological Chemistry 273 (19), 11867-11873, 1998 | 246 | 1998 |
| Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated … GMC Rosano, J Tamargo, KP Kjeldsen, M Lainscak, S Agewall, SD Anker, ... European Heart Journal–Cardiovascular Pharmacotherapy 4 (3), 180-188, 2018 | 222 | 2018 |
| Angiotensin-(1-7) with thioether bridge: an angiotensin-converting enzyme-resistant, potent angiotensin-(1-7) analog LD Kluskens, SA Nelemans, R Rink, L de Vries, A Meter-Arkema, Y Wang, ... The Journal of Pharmacology and Experimental Therapeutics 328 (3), 849-854, 2009 | 210 | 2009 |
| Nonpeptide AVE 0991 is an angiotensin-(1–7) receptor Mas agonist in the mouse kidney SVB Pinheiro, AC Simoes e Silva, WO Sampaio, RD de Paula, ... Hypertension 44 (4), 490-496, 2004 | 186 | 2004 |
| Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature T Walther, G Wallukat, A Jank, S Bartel, HP Schultheiss, R Faber, ... Hypertension 46 (6), 1275-1279, 2005 | 185 | 2005 |
| Baroreflex sensitivity, heart rate, and blood pressure variability in normal pregnancy A Voss, H Malberg, A Schumann, N Wessel, T Walther, H Stepan, R Faber American journal of hypertension 13 (11), 1218-1225, 2000 | 179 | 2000 |
| Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain LK Becker, GM Etelvino, T Walther, RAS Santos, MJ Campagnole-Santos American Journal of Physiology-Heart and Circulatory Physiology 293 (3 …, 2007 | 175 | 2007 |
| Angiotensin-(1–7) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas K Hellner, T Walther, M Schubert, D Albrecht Molecular and Cellular Neuroscience 29 (3), 427-435, 2005 | 174 | 2005 |
| The endothelium-dependent vasodilator effect of the nonpeptide Ang (1-7) mimic AVE 0991 is abolished in the aorta of mas-knockout mice VS Lemos, DMR Silva, T Walther, N Alenina, M Bader, RAS Santos Journal of cardiovascular pharmacology 46 (3), 274-279, 2005 | 165 | 2005 |
| Differential regulation of in vivo angiogenesis by angiotensin II receptors T Walther, A Menrad, HD Orzechowski, G Siemeister, M Paul, M Schirner The FASEB Journal 17 (14), 2061-2067, 2003 | 163 | 2003 |
| Inhibition of pressure natriuresis in mice lacking the AT2 receptor V Gross, WH Schunck, H Honeck, AF Milia, E Kärgel, T Walther, M Bader, ... Kidney international 57 (1), 191-202, 2000 | 157 | 2000 |
| Angiotensin-(1–7) and the g protein-coupled receptor MAS are key players in renal inflammation V Esteban, S Heringer-Walther, A Sterner-Kock, R de Bruin, ... PloS one 4 (4), e5406, 2009 | 154 | 2009 |
| Transgenic activation of the kallikrein‐kinin system inhibits intramyocardial inflammation, endothelial dysfunction, and oxidative stress in experimental diabetic cardiomyopathy C Tschöpe, T Walther, F Escher, F Spillmann, J Du, C Altmann, I Schimke, ... The FASEB journal 19 (14), 2057-2059, 2005 | 150 | 2005 |
| Multiple interactions between the renin-angiotensin and the kallikrein-kinin systems: role of ACE inhibition and AT1 receptor blockade C Tschöpe, HP Schultheiss, T Walther Journal of cardiovascular pharmacology 39 (4), 478-487, 2002 | 148 | 2002 |
